US SEC Trading Suspension Halt Orders — July 22, 2026

Received delisting notice with 180-day cure period until January 19, 2027; no insider buying or capital allocation actions reported, indicating management may lack conviction in a turnaround

Executed 1-for-25 reverse stock split effective July 20, 2026, bringing stock price to $7.12; this is a short-term fix but does not address underlying business fundamentals

Nasdaq Hearings Panel granted continued listing subject to compliance by July 31, 2026; this creates a high-stakes binary event with only 9 days to demonstrate compliance

No forward-looking guidance or insider activity reported; lack of communication suggests management may be uncertain about future prospects

Stockholders approved reverse split range of 1-for-10 to 1-for-30; Board chose aggressive 1-for-25 ratio, indicating severe price depression and need for drastic action

Potential eligibility for additional 180-day extension by moving to Nasdaq Capital Market; this provides a lifeline but requires meeting other listing standards, which may be challenging

Initial non-compliance notice received November 5, 2025; company has been in non-compliance for over 8 months, indicating persistent structural issues

No period-over-period comparisons available; lack of financial data in filing suggests company may be in a quiet period or avoiding disclosure

Received delisting notice on July 21, 2026; if unable to cure by January 19, 2027, shares could be delisted, leading to significant liquidity loss and potential bankruptcy

Must demonstrate compliance with $1.00 minimum bid price by July 31, 2026; failure will result in delisting, with only 9 days remaining

No insider buying reported; management may lack confidence in the company's ability to regain compliance or execute a turnaround

1-for-25 reverse split reduces share count by 96%, which may deter retail investors and create negative sentiment; historical data shows reverse splits often precede further declines

No capital allocation data (dividends, buybacks) reported; company may be conserving cash but also indicates no shareholder returns

Non-compliance since November 2025; prolonged period suggests deep-rooted operational or financial issues beyond just stock price

To qualify for additional 180-day extension, must meet market value of publicly held shares and all other initial listing standards for Nasdaq Capital Market; failure to meet these could accelerate delisting

No forward-looking statements or guidance provided; lack of transparency increases uncertainty and risk for investors

If SunPower can regain compliance by January 19, 2027, through organic price appreciation or reverse split, shares could see significant upside; current price may be undervalued if turnaround is successful

Reverse split effective July 20, 2026, brought stock to $7.12; if company demonstrates compliance by July 31, 2026, short-term momentum could attract momentum traders

Potential to move to Nasdaq Capital Market and gain additional 180 days; this provides time for operational improvements or strategic alternatives

Panel granted continued listing subject to compliance; this shows Nasdaq is willing to work with the company, reducing immediate delisting risk

No insider selling reported; management may be holding shares, indicating belief in a potential recovery

Stockholders approved reverse split, showing support for management's plan; this could indicate a committed shareholder base

The 180-day cure period provides a defined timeline for potential catalysts such as new contracts, partnerships, or financing

1-for-25 ratio suggests management is taking aggressive action to ensure compliance; if successful, it could restore investor confidence

Both SunPower (solar) and Purple Innovation (consumer goods) face delisting due to sub-$1 stock prices, indicating a broader trend of small-cap companies struggling to maintain listing standards amid market volatility and sector-specific headwinds

Both companies are considering or have executed reverse stock splits to meet minimum bid price requirements; this pattern suggests that many distressed companies use splits as a temporary solution without addressing underlying fundamentals

Neither filing reported insider buying or selling; this absence of insider activity may indicate that management is avoiding signaling or is unable to trade due to blackout periods, creating uncertainty for investors

Purple Innovation's Hearings Panel granted continued listing subject to compliance, and SunPower may qualify for an additional 180-day extension; this shows Nasdaq is providing flexibility to distressed companies, but with strict deadlines

Neither filing included revenue, margin, or operational metrics; this lack of financial data in delisting-related filings limits the ability to assess fundamental trends and increases reliance on stock price movements

Must demonstrate compliance with $1.00 minimum bid price by July 31, 2026; watch for stock price action and any Nasdaq announcements

180-day cure period ends January 19, 2027; monitor for any reverse stock split announcements, insider buying, or operational updates

If SunPower fails to cure by January 19, 2027, watch for application to move to Nasdaq Capital Market for additional 180-day extension

Reverse split effective July 20, 2026; monitor for sustained trading above $1.00 and any insider transactions following the split

Watch for any insider buying or selling in the coming weeks; insider buying could signal management confidence in a turnaround

No forward guidance provided; watch for earnings releases or business updates that could impact stock price and compliance prospects

Monitor for any 8-K or other SEC filings that may provide additional details on compliance plan or financial condition

If SunPower announces a reverse split, watch for the ratio and effective date; historical patterns show reverse splits often lead to further declines